National Human Genome Research Institute; Notice of Meeting, 80555 [2022-28447]
Download as PDF
Federal Register / Vol. 87, No. 250 / Friday, December 30, 2022 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; RFP
Review: National NeuroHIV Tissue
Consortium (NNTC) Clinical Sites and Data
Coordination Centers.
Date: January 24, 2023.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Nicholas Gaiano, Ph.D.,
Review Branch Chief, Division of Extramural
Activities, National Institute of Mental
Health, National Institutes of Health,
Neuroscience Center/Room 6150/MSC 9606,
6001 Executive Boulevard, Bethesda, MD
20892–9606, 301–443–2742, nick.gaiano@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: December 27, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–28446 Filed 12–29–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Initial Review Group;
Effectiveness of Mental Health Interventions
Study Section.
Date: February 3, 2023.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:08 Dec 29, 2022
Jkt 259001
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Room 6143, MSC 9606, Bethesda, MD 20892–
9606, 301–443–9699, bursteinme@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: December 27, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–28445 Filed 12–29–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the
public as indicated below. Individuals
who need special assistance, such as
sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will be videocast and can be accessed
from https://www.genome.gov/aboutnhgri/Institute-Advisors/NationalAdvisory-Council-for-Human-GenomeResearch.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: February 13–14, 2023.
Closed: February 13, 2023, 10:00 a.m. to
11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
80555
Rockledge Drive, Suite 1100, Bethesda, MD
20892 (Virtual Meeting).
Open: February 13, 2023, 11:30 a.m. to 6:00
p.m.
Agenda: Report of Institute Director and
Institute Staff.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20817 (Virtual Meeting).
Closed: February 14, 2023, 10:00 a.m. to
5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Suite 1100, Bethesda, MD
20817 (Virtual Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 6700 Rockledge Drive, Suite 1100,
Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
Any interested person may file written
comments with the committee within 15
days after the meeting by forwarding the
statement to the Contact Person listed on this
notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.genome.gov/council, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: December 27, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–28447 Filed 12–29–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental and
Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Dental
and Craniofacial Research Council.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting, should notify the
Contact Person listed below in advance
of the meeting. The open session will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
E:\FR\FM\30DEN1.SGM
30DEN1
Agencies
[Federal Register Volume 87, Number 250 (Friday, December 30, 2022)]
[Notices]
[Page 80555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-28447]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the public as indicated below.
Individuals who need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The meeting will
be videocast and can be accessed from https://www.genome.gov/about-nhgri/Institute-Advisors/National-Advisory-Council-for-Human-Genome-Research.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Human Genome
Research.
Date: February 13-14, 2023.
Closed: February 13, 2023, 10:00 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda,
MD 20892 (Virtual Meeting).
Open: February 13, 2023, 11:30 a.m. to 6:00 p.m.
Agenda: Report of Institute Director and Institute Staff.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda,
MD 20817 (Virtual Meeting).
Closed: February 14, 2023, 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Suite 1100, Bethesda,
MD 20817 (Virtual Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, 6700 Rockledge Drive, Suite 1100, Rockville, MD 20852,
(301) 402-0838, [email protected].
Any interested person may file written comments with the
committee within 15 days after the meeting by forwarding the
statement to the Contact Person listed on this notice. The statement
should include the name, address, telephone number and when
applicable, the business or professional affiliation of the
interested person.
Information is also available on the Institute's/Center's home
page: https://www.genome.gov/council, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: December 27, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-28447 Filed 12-29-22; 8:45 am]
BILLING CODE 4140-01-P